-
Metelimumab (CAT-192) is a
human IgG4
monoclonal antibody that
neutralizes TGF beta 1
which had been
chosen for
further development for the treatment...
- (INN)
metazamide (INN)
metazide (INN)
metazocine (INN)
metbufen (INN)
metelimumab (INN)
meteneprost (INN)
metenolone (INN)
metergoline (INN) metergotamine...
- (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761 Galunisertib...
-
drugs metelimumab (CAT-192) and
fresolimumab with Genzyme.
During early development,
around 2004, CAT
decided to drop
development of
metelimumab in favour...
- CD154
Frexalimab Ruplizumab BLyS
Belimumab CAT
Bertilimumab Lerdelimumab Metelimumab Integrin Natalizumab Vedolizumab Interleukin-6
receptor Tocilizumab LFA-1...
- (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761 Galunisertib...
- (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761 Galunisertib...
-
Mepolizumab Bosatria mab
humanized IL-5 Y
asthma and
white blood cell
diseases Metelimumab mab
human TGF-β1
systemic scleroderma Milatuzumab mab
humanized CD74...
- (BMP3B), 11 (BMP11)) TGFβ (1, 2, 3) Antibodies:
Fresolimumab Lerdelimumab Metelimumab Kinase inhibitors: A 83-01 D-4476 GW-788388 LY-364947 LY-2109761 Galunisertib...
-
Lanadelumab Lenzilumab Lerdelimumab Lirentelimab Lirilumab Mavrilimumab Metelimumab Morolimumab Namilumab Oleclumab Oxelumab§
Pamrevlumab Placulumab Relatlimab†...
